Can You Skip Chemotherapy for Colorectal Cancer? Almost every decision made by cancer patients is about risk. Undergoing treatment can bring the risk of different side effects. Not undergoing treatment brings different risks.
I am a long-term survivor of an incurable blood cancer called multiple myeloma.
I was initially diagnosed with a form of pre-cancer. I was told that no treatment was necessary. But I was diagnosed with cancer less than a year later.
I often wonder about early-stage cancers and the trade-offs between different decisions. I think it’s important for all cancer patients to understand the risks and benefits of different treatment options.
My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
On that note, the video below does a great job of explaining the issue of chemo or no chemo. However, and maybe this is just my issue with the words that oncologists use, but no therapy plan is 100% either curative or not. It’s all about weighing the risks and benefits of undergoing therapy.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.
Good luck,
Some colorectal cancer patients can safely skip chemotherapy, but it depends heavily on stage, risk factors, and tumor biology.
If you’ve been diagnosed with colorectal cancer, one of the first questions you may ask is:
“Do I really need chemotherapy?”
The answer is not the same for everyone.
Unlike many cancers, where chemotherapy is routine, colorectal cancer treatment is highly stage-dependent, and in some cases, chemotherapy offers only modest or no benefit.
For most patients, colorectal cancer treatment includes:
The key issue is whether chemotherapy meaningfully improves survival or reduces recurrence risk.
Chemotherapy: NOT needed
👉 Skipping chemotherapy is standard of care.
Chemotherapy: Sometimes avoidable
This is where things get complicated.
Doctors look for “high-risk features,” including:
Even then, the benefit is modest and debated.
👉 Many Stage II patients can safely skip chemotherapy, especially if low-risk.
Chemotherapy: Usually recommended
Here, the evidence is much stronger.
👉 Skipping chemotherapy in Stage III carries a higher risk of recurrence and reduced survival.
Even when chemotherapy is recommended, some patients decline it due to:
A 3–5% survival gain may not justify toxicity for some patients.
Common issues include:
Some patients prioritize:
Patients may explore:
(Important: these should complement—not replace—evidence-based care without careful evaluation.)
The future of colorectal cancer treatment is personalization.
Not all patients benefit equally from chemotherapy.
Emerging tools include:
These help identify:
If you’re considering skipping chemotherapy, ask:
Regardless of your decision, evidence supports:
These approaches may:
👉 The decision is not “yes or no”—it’s risk vs. benefit, personalized to you.
Link this article to: